|
Brimonidine TartrateDrug - Brimonidine Tartrate The trade name of the product as shown on the labeling.
Dosage -
SOLUTION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Brimonidine Tartrate
Strength -
0.2%
Applicant -
ALCON
New Drug Application (NDA) Number -
076254
Product Number -
001
Therapeutic Equivalence (TE) Code -
AT
Approval Date -
Sep 16, 2003
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Alcon Inc
Brimonidine Tartrate
Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection
Bretylium Tosylate In Dextrose 5% In Plastic Container 800mg/100ml Injectable; Injection Bretylium Tosylate In Plastic Container 50mg/ml Injectable; Injection Bretylol 50mg/ml Injectable; Injection Alphagan 0.2% Solution/drops; Ophthalmic Alphagan 0.5% Solution/drops; Ophthalmic Alphagan P 0.1% Solution/drops; Ophthalmic Alphagan P 0.15% Solution/drops; Ophthalmic Brimonidine Tartrate 0.2% Solution/drops; Ophthalmic Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection NewDrugInformation |